This program will provide an overview of the opportunities and challenges expected in bringing genome editing from the laboratory to the beside. Hear from leading experts on the science behind genome editing; challenges in the IP landscape; learn about what is happening at NIST to set industry standards; hear about anticipated challenges from a public policy perspective, and gain a high-level overview on product development strategies to ensure plans are scientifically sound and meet regulatory expectations and clinical objectives.